Bio.Law

Law for Life Science Companies

Imprint | Terms of Use | Privacy Policy

All rights reserved

NEUWERK, Hamburg © 2019

  • Black LinkedIn Icon
  • xing_4096_black
  • Black Facebook Icon
  • telephone-picto-copie-298x300-298x300
  • mail-4

PRivate equity & Venture Capital

We help innovative entrepreneurs.

And we do so by working together with the most influential sources of funding: venture capital and private equity firms. Our clients include private equity funds, family offices, business angels, and strategic investors active in the biotech, medical devices and pharma sectors.

Our teams assist clients during every phase of the investment process, from early stage angel investments all the way through to exit. We are intimately familiar with a wide range of financing tools, and have in-depth experience in structuring management and employee participation schemes.

With our expertise in the life sciences and healthcare field, we support our clients in finding the right legal framework for their investment interests. Our M&A and corporate finance teams work hand-in-hand with our employment, IP/IT, regulatory and litigation specialists – seamlessly and efficiently.

 

We know that, when the right opportunity arises, you need to be fast. That is why our approach is no-nonsense, fully responsive, hands-on and commercially-minded. Our clients value us as their trusted advisor – in good and bad times.

Our services for private equity & venture capital clients include:

  • growth financing

  • implementation of financing rounds

  • leveraged, secondary, or tertiary buy-outs

  • sector-specific financing instruments, such as royalty financing

  • venture debts and mezzanine financing

  • convertible loans and silent partnerships

  • spin-offs

  • purchases from insolvency

  • co-investment and minority stakes

  • public takeovers

  • conducting buyer's due diligence

  • cross-border acquisition structuring

  • investment structuring between investors, co-investors, management and (if appropriate) the former owners

  • management/employee participation schemes

  • transaction-related litigation/arbitration